2026-04-17T06:59:46Zhttps://recercat.cat/oai/request

oai:recercat.cat:2072/4272922026-03-28T05:10:59Zcom_2072_98col_2072_378192

00925njm 22002777a 4500 dc Palomo Sanchís, Laura author García, Olga author Arnan, Montserrat author Xicoy, Blanca author Fuster García, Francisco author Cabezón, Marta author Coll, Rosa author Ademà, Vera author Grau Cat, Javier author Jiménez, Maria-José author Pomares, Helena author Marcé, Silvia author Mallo, Maria del Mar author Millá, Fuensanta author Alonso, Esther author Sureda, Anna author Gallardo, David author Feliu Frasnedo, Evarist author Ribera, Jose-Maria author Sole, F. author Zamora, Lurdes author 2016 Clonal cytogenetic abnormalities are found in 20-30% of patients with chronic myelomonocytic leukemia (CMML), while gene mutations are present in. Chronic myelomonocytic leukemia Normal karyotype Gene mutations Targeted deep sequencing Prognostic factors Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features